Blend Labs, Inc. Class A BLND 深 沪
等待开盘 05-27 09:30:00 美东时间
1.475
+0.005
+0.34%
华盛通- 最 高1.4899
- 今 开1.47
- 成交量 312.64万股
- 最 低 1.43
- 昨 收 1.47
- 总市值 3.57亿
- 52周最高 4.49
- 市盈率 静 --
- 换手率 1.29%
- 52周最低 1.175
- 委 比 63.02%
- 总股本 2.42亿
- 历史最高 21.04
- 量 比 0.63
- 振 幅 4.07%
- 历史最低 0.5286
- 每 手 1
- 风险率 0.85%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 应用材料获17家大行集体上调目标价；Bitdeer 、Forgent 、嘉信理财、Viking等获多家大行上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从11美元升至12美元；Ladenburg Thalmann：维持Usio"买入"评级，目标价从5.75美元升至6.25美元
05-18 11:48
Canaccord Genuity Maintains Buy on Blend Labs, Lowers Price Target to $4.5
Canaccord Genuity analyst Joseph Vafi maintains Blend Labs (NYSE:BLND) with a Buy and lowers the price target from $5.25 to $4.5.
05-15 20:02
美股大行评级 | 爱彼迎、Affirm、CoreWeave、Datadog、微芯科技等获多家大行上调目标价；HubSpot惨遭14家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从15美元升至35美元；韦德布什：维持Cullinan Therapeutics"跑赢大市"评级，目标价从36美元升至37美元
05-11 15:43
Blend Labs shares are trading lower after the company reported worse-than-expected Q1 adjusted EPS results and issued Q2 sales guidance below estimates.
Blend Labs shares are trading lower after the company reported worse-than-expec...
05-08 05:28
Shares of companies in the broader software sector are trading lower amid a pullback in sentiment after Q1 financial results and outlook comments from industry peers IBM and ServiceNow.
Shares of companies in the broader software sector are trading lower amid a pul...
04-24 02:46
Shares of companies within the broader technology sector are trading higher amid optimism that the Middle East conflict will conclude soon, which may ease inflation and rate-hike fears.
Shares of companies within the broader technology sector are trading higher ami...
04-02 03:50
美股大行评级 | 甲骨文绩后分歧大！小摩上调评级至"超配"，目标价缺降至210美元；科尔士百货、AVAV、Blend Labs、Domo遭多家大行下调评级
今日重点评级关注：LUCID CAPITAL MARKETS：上调INmune Bio评级至"买入" 目标价从2美元升至9美元；Clear Street：维持MoonLake Immunotherapeutics Class A"买入"评级，目标价从45美元升至70美元
03-12 12:34
Citizens Maintains Market Outperform on Blend Labs, Lowers Price Target to $5
Citizens analyst Aaron Kimson maintains Blend Labs (NYSE:BLND) with a Market Outperform and lowers the price target from $7 to $5.
03-11 19:32
Blend Labs Q4 Earnings Summary & Key Takeaways
Blend Labs (NYSE:BLND) reported its Q4 earnings results on Tuesday, March 10, 2...
03-11 04:08
Blend Labs: Q4 Earnings Insights
Blend Labs (NYSE:BLND) reported its Q4 earnings results on Tuesday, March 10, 2...
03-11 04:02
